Computer-aided detection developer Rcadia Medical Imaging has closed a $3.3 million investment round led by BioVentures of Cambridge, MA.
Existing investors, including 20/20 HealthCare Partners, also participated in the financing, according to the Haifa, Israel-based firm. Rcadia said it would use the proceeds to fund the commercial launch of its COR Analyzer software and the establishment of a U.S. office.
Related Reading
Rcadia debuts COR Analyzer for coronary CTA, December 3, 2008
Rcadia adds distributor, November 20, 2007
Rcadia establishes U.S. beta site, October 30, 2007
Rcadia nets FDA nod, September 26, 2007
Rcadia receives FDA OK, February 14, 2007
Copyright © 2008 AuntMinnie.com